MTHFR and chronic myelogenous leukemia, BCR-ABL1 positive: Lordelo et al. showed that the AC genotype of the MTHFR 1298 A>C polymorphism significantly decreased the risk of CML, particularly in the case of young adult females (p = 0.047) (3).